Rxsight Inc
NASDAQ:RXST

  • LAST PRICE
    48.0100
  • TODAY'S CHANGE (%)
    -2.8400 (-5.5851%)
  • Bid / Lots
    45.0000/ 1
  • Ask / Lots
    51.4000/ 1
  • Open / Previous Close
    47.0300 / 50.8500
  • Day Range
    42.5500
    49.2500
  • 52 Week Range
    22.9100
    66.5400
  • Volume
    2,837,243

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Nov 7, 2024

      Show headlines and story abstract

    • 4:34PM ET on Thursday Nov 07, 2024 by MT Newswires
      Companies Mentioned: RXST
      04:34 PM EST, 11/07/2024 (MT Newswires) -- ...

    • 4:34PM ET on Thursday Nov 07, 2024 by MT Newswires
      Companies Mentioned: RXST
      04:34 PM EST, 11/07/2024 (MT Newswires) -- ...

    • 4:05PM ET on Thursday Nov 07, 2024 by Dow Jones
      Companies Mentioned: RXST
      Net loss $ (6,338) $ (12,415) $ (21,517) $ (39,431) ========== ========== ========== ========== Other comprehensive (loss) income Unrealized gain on short-term investments 633 19 524 38 Foreign currency translation gain (loss) 6 (6) 2 (3) ---------- ---------- ---------- ---------- Total other comprehensive income 639 13 526 35 ---------- ---------- ---------- ---------- Comprehensive loss $ (5,699) $ (12,402) $ (20,991) $ (39,396) ========== ========== ========== ========== Net loss per share: Basic & diluted $ (0.16) $ (0.35) $ (0.56) $ (1.16) Weighted-average shares used in computing net loss per share: Attributable to common stock, basic & diluted 39,788,621 35,662,397 38,367,759 33,947,331 RxSIGHT, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (In thousands, except share and per share amounts) September 30, December 31, 2024 2023 --------------- -------------- (Unaudited) Assets Current assets: Cash and cash equivalents $ 16,720 $ 9,692 Short-term investments 220,400 117,490 Accounts receivable, net 25,368 20,281 Inventories, net 21,673 17,421 Prepaid and other current assets 2,607 3,523 ----------- ---------- Total current assets 286,768 168,407 Property and equipment, net 12,241 10,841 Operating leases right-of-use assets 10,536 2,444 Restricted cash 711 711 Other assets 213 147 ----------- ---------- Total assets $ 310,469 $ 182,550 =========== ========== Liabilities and stockholders' equity Current liabilities: Accounts payable $ 4,581 $ 3,863 Accrued expenses and other current liabilities 17,323 15,239 Lease liabilities 734 1,801 ----------- ---------- Total current liabilities 22,638 20,903 Long-term lease liabilities 10,570 1,211 Other long-term liabilities -- 74 ----------- ---------- Total liabilities 33,208 22,188 ----------- ---------- Commitments and contingencies Stockholders' equity: Common stock, $0.001 par value, 900,000,000 shares authorized, 40,254,105 shares issued and outstanding as of September 30, 2024 and 36,139,513 shares issued and outstanding as of December 31, 2023 40 36 Preferred stock, $0.001 par value, 100,000,000 shares authorized, no shares issued and outstanding -- -- Additional paid-in capital 892,857 754,971 Accumulated other comprehensive income (loss) 521 (5) Accumulated deficit (616,157) (594,640) ----------- ---------- Total stockholders' equity 277,261 160,362 ----------- ---------- Total liabilities and stockholders' equity $ 310,469 $ 182,550 =========== ==========

    • 4:05PM ET on Thursday Nov 07, 2024 by Dow Jones
      Companies Mentioned: RXST
      Net loss $ (6,338) $ (12,415) $ (21,517) $ (39,431) ========== ========== ========== ========== Other comprehensive (loss) income Unrealized gain on short-term investments 633 19 524 38 Foreign currency translation gain (loss) 6 (6) 2 (3) ---------- ---------- ---------- ---------- Total other comprehensive income 639 13 526 35 ---------- ---------- ---------- ---------- Comprehensive loss $ (5,699) $ (12,402) $ (20,991) $ (39,396) ========== ========== ========== ========== Net loss per share: Basic & diluted $ (0.16) $ (0.35) $ (0.56) $ (1.16) Weighted-average shares used in computing net loss per share: Attributable to common stock, basic & diluted 39,788,621 35,662,397 38,367,759 33,947,331 RxSIGHT, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (In thousands, except share and per share amounts) September 30, December 31, 2024 2023 --------------- -------------- (Unaudited) Assets Current assets: Cash and cash equivalents $ 16,720 $ 9,692 Short-term investments 220,400 117,490 Accounts receivable, net 25,368 20,281 Inventories, net 21,673 17,421 Prepaid and other current assets 2,607 3,523 ----------- ---------- Total current assets 286,768 168,407 Property and equipment, net 12,241 10,841 Operating leases right-of-use assets 10,536 2,444 Restricted cash 711 711 Other assets 213 147 ----------- ---------- Total assets $ 310,469 $ 182,550 =========== ========== Liabilities and stockholders' equity Current liabilities: Accounts payable $ 4,581 $ 3,863 Accrued expenses and other current liabilities 17,323 15,239 Lease liabilities 734 1,801 ----------- ---------- Total current liabilities 22,638 20,903 Long-term lease liabilities 10,570 1,211 Other long-term liabilities -- 74 ----------- ---------- Total liabilities 33,208 22,188 ----------- ---------- Commitments and contingencies Stockholders' equity: Common stock, $0.001 par value, 900,000,000 shares authorized, 40,254,105 shares issued and outstanding as of September 30, 2024 and 36,139,513 shares issued and outstanding as of December 31, 2023 40 36 Preferred stock, $0.001 par value, 100,000,000 shares authorized, no shares issued and outstanding -- -- Additional paid-in capital 892,857 754,971 Accumulated other comprehensive income (loss) 521 (5) Accumulated deficit (616,157) (594,640) ----------- ---------- Total stockholders' equity 277,261 160,362 ----------- ---------- Total liabilities and stockholders' equity $ 310,469 $ 182,550 =========== ==========

  • Oct 29, 2024

Peers Headlines